{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/08/27/3352365/34323/en/roivant-announces-fda-approval-of-lisraya-brepocitinib-for-adults-with-dermatomyositis-now-available-in-the-u-s.html", "message": "News view counter 905590 successfully enlarged"}